(Washington University School of Medicine) Using CRISPR technology, a team of researchers led by Farshid Guilak, PhD, at Washington University School of Medicine in St. Louis, rewired stem cells' genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2pDznX1
No comments:
Post a Comment